Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$36.7B
sum of reported positions
Reported positions
504
Changes vs prior quarter
450
52 new · 45 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 508 measured positions in 8 quarters, the typical new or larger position finished −4.0 pts against the S&P 500 and 40% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 15.5M | $672M | 1.8% | |
| 29.1M | $623M | 1.7% | |
| 8.93M | $486M | 1.3% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $29.7B | $36.7B |
| Positions | 497 | 504 |
| Biggest line | — | Amcor 2% |
| 542K |
| $465M |
| 1.3% |
| 1.48M | $448M | 1.2% |
| 11.1M | $433M | 1.2% |
| 857K | $414M | 1.1% |
| 2.63M | $413M | 1.1% |
| 11.4M | $412M | 1.1% |
| 1.64M | $395M | 1.1% |
| 2.63M | $394M | 1.1% |
| 440K | $365M | 1.0% |
| 13.8M | $358M | 1.0% |
| 1.01M | $337M | 0.9% |
| 2.96M | $326M | 0.9% |
| 8.42M | $320M | 0.9% |
| 13.1M | $320M | 0.9% |
| 16.7M | $319M | 0.9% |
| 1.21M | $318M | 0.9% |
| 12M | $317M | 0.9% |
| 5.45M | $307M | 0.8% |
| 894K | $302M | 0.8% |
| 1.12M | $298M | 0.8% |
| 2.62M | $296M | 0.8% |
| 772K | $291M | 0.8% |
Ralliant Corp (RAL)
2.26M shares
MaxLinear, Inc. (MXL)
1.28M shares
MYR Group, Inc. (MYRG)
287K shares
Valmont Industries (VMI)
246K shares
AAON (AAON)
918K shares
Prestige Consumer Healthcare (PBH)
2.33M shares
Cathay General Bancorp (CATY)
1.72M shares
Liquidia Corporation (LQDA)
1.21M shares
PTC Therapeutics, Inc. (PTCT)
1.16M shares
Jfrog (FROG)
1.03M shares
StandardAero (SARO)
3.13M shares
Arrow Electronics (ARW)
407K shares
WillScot Holdings Corp. (WSC)
2.89M shares
ACM Research, Inc. (ACMR)
639K shares
Lear (LEA)
597K shares
Dycom Industries (DY)
156K shares
Sensient Technologies (SXT)
612K shares
Glaukos Corp. (GKOS)
530K shares
FactSet (FDS)
302K shares
Churchill Downs Inc. (CHDN)
729K shares
Corcept Therapeutics (CORT)
710K shares
SM Energy Company (SM)
2.28M shares
Vishay Intertechnology (VSH)
1.1M shares
Celcuity (CELC)
514K shares
Dynatrace (DT)
1.23M shares
